Cargando…

Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China

OBJECTIVE: To investigate the clinical characteristics of patients with multiple endocrine neoplasia type 1 (MEN1)-related insulinoma and their relationship with specific biochemical changes and to summarize the features of treatment options for the Chinese population with this disease and the impac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuan, Yu, Jie, Liu, Yiwen, Lyu, Lu, Ping, Fan, Xu, Lingling, Li, Wei, Wang, Ou, Xu, Qiang, Wu, Wenming, Zhang, Huabing, Li, Yuxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195405/
https://www.ncbi.nlm.nih.gov/pubmed/35698198
http://dx.doi.org/10.1186/s13023-022-02370-1
_version_ 1784726957965967360
author Zhao, Yuan
Yu, Jie
Liu, Yiwen
Lyu, Lu
Ping, Fan
Xu, Lingling
Li, Wei
Wang, Ou
Xu, Qiang
Wu, Wenming
Zhang, Huabing
Li, Yuxiu
author_facet Zhao, Yuan
Yu, Jie
Liu, Yiwen
Lyu, Lu
Ping, Fan
Xu, Lingling
Li, Wei
Wang, Ou
Xu, Qiang
Wu, Wenming
Zhang, Huabing
Li, Yuxiu
author_sort Zhao, Yuan
collection PubMed
description OBJECTIVE: To investigate the clinical characteristics of patients with multiple endocrine neoplasia type 1 (MEN1)-related insulinoma and their relationship with specific biochemical changes and to summarize the features of treatment options for the Chinese population with this disease and the impact on long-term prognosis. METHODS: “MEN1” and “insulinoma” were used when searching the Peking Union Medical College Hospital (PUMCH) medical record retrieval system to obtain clinical information about patients. We identified patients diagnosed with MEN1-associated insulinoma based on endocrinological, radiological, and pathological examinations, and subsequently analyzed their clinical data. RESULTS: A total of 55 patients with MEN1-associated insulinoma were included, including 29 (52.7%) men and 26 (47.3%) women. The parathyroid gland was the most commonly affected (78.2%), followed by the pituitary gland (69.1%) and adrenal gland (16.4%). Insulinoma was the first manifestation of MEN1 in at least 23.6% (13/55) of patients. Nineteen (34.5%) patients presented with initial symptoms of hypoglycemia before the age of 22 years. Among the 24 Patients with high serum calcium (Ca) had significantly lower serum insulin levels than those with normal serum Ca levels (p < 0.001) during hypoglycemic episodes. However, serum C-peptide level at 0.5 h and serum insulin level at 1 h was higher in patients with hypercalcemia than in patients with normal serum Ca levels in the oral glucose tolerance test (OGTT), although the differences were not statistically significant. Multifocal pancreatic neuroendocrine tumors (pNETs) were present in 38 (69.1%) patients; most of them (55.6%, 20/36) underwent multiple enucleations, and 45% (9/20) had a postoperative recurrence. Five patients (10%) who underwent distal pancreatectomy developed pancreatic insufficiency after an average of seven years. patients who underwent genetic testing, 23 (95.8%) were positive for MEN1 mutation, with mutations most commonly found in exons 2 (21.7%) and 3 (13%). CONCLUSIONS: In our study, the rates of postoperative recurrence and long-term complications in patients with MEN1 with multifocal pNETs were significantly different from those in other international centers and might be related to the choice of surgical method. In addition, elevated serum Ca levels in patients with primary hyperparathyroidism may affect insulin secretion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02370-1.
format Online
Article
Text
id pubmed-9195405
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91954052022-06-15 Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China Zhao, Yuan Yu, Jie Liu, Yiwen Lyu, Lu Ping, Fan Xu, Lingling Li, Wei Wang, Ou Xu, Qiang Wu, Wenming Zhang, Huabing Li, Yuxiu Orphanet J Rare Dis Research OBJECTIVE: To investigate the clinical characteristics of patients with multiple endocrine neoplasia type 1 (MEN1)-related insulinoma and their relationship with specific biochemical changes and to summarize the features of treatment options for the Chinese population with this disease and the impact on long-term prognosis. METHODS: “MEN1” and “insulinoma” were used when searching the Peking Union Medical College Hospital (PUMCH) medical record retrieval system to obtain clinical information about patients. We identified patients diagnosed with MEN1-associated insulinoma based on endocrinological, radiological, and pathological examinations, and subsequently analyzed their clinical data. RESULTS: A total of 55 patients with MEN1-associated insulinoma were included, including 29 (52.7%) men and 26 (47.3%) women. The parathyroid gland was the most commonly affected (78.2%), followed by the pituitary gland (69.1%) and adrenal gland (16.4%). Insulinoma was the first manifestation of MEN1 in at least 23.6% (13/55) of patients. Nineteen (34.5%) patients presented with initial symptoms of hypoglycemia before the age of 22 years. Among the 24 Patients with high serum calcium (Ca) had significantly lower serum insulin levels than those with normal serum Ca levels (p < 0.001) during hypoglycemic episodes. However, serum C-peptide level at 0.5 h and serum insulin level at 1 h was higher in patients with hypercalcemia than in patients with normal serum Ca levels in the oral glucose tolerance test (OGTT), although the differences were not statistically significant. Multifocal pancreatic neuroendocrine tumors (pNETs) were present in 38 (69.1%) patients; most of them (55.6%, 20/36) underwent multiple enucleations, and 45% (9/20) had a postoperative recurrence. Five patients (10%) who underwent distal pancreatectomy developed pancreatic insufficiency after an average of seven years. patients who underwent genetic testing, 23 (95.8%) were positive for MEN1 mutation, with mutations most commonly found in exons 2 (21.7%) and 3 (13%). CONCLUSIONS: In our study, the rates of postoperative recurrence and long-term complications in patients with MEN1 with multifocal pNETs were significantly different from those in other international centers and might be related to the choice of surgical method. In addition, elevated serum Ca levels in patients with primary hyperparathyroidism may affect insulin secretion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02370-1. BioMed Central 2022-06-13 /pmc/articles/PMC9195405/ /pubmed/35698198 http://dx.doi.org/10.1186/s13023-022-02370-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhao, Yuan
Yu, Jie
Liu, Yiwen
Lyu, Lu
Ping, Fan
Xu, Lingling
Li, Wei
Wang, Ou
Xu, Qiang
Wu, Wenming
Zhang, Huabing
Li, Yuxiu
Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China
title Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China
title_full Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China
title_fullStr Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China
title_full_unstemmed Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China
title_short Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China
title_sort analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195405/
https://www.ncbi.nlm.nih.gov/pubmed/35698198
http://dx.doi.org/10.1186/s13023-022-02370-1
work_keys_str_mv AT zhaoyuan analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT yujie analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT liuyiwen analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT lyulu analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT pingfan analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT xulingling analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT liwei analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT wangou analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT xuqiang analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT wuwenming analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT zhanghuabing analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina
AT liyuxiu analysisof55patientswithmultipleendocrineneoplasiatype1associatedinsulinomafromasinglecenterinchina